Hexarelin Research Peptide: Mechanism & Lab Studies | Palmetto Peptides

Hexarelin Research Peptide: Complete Guide to Mechanism, Studies, and Lab Applications

Research Use Only: Hexarelin is not approved by the FDA for human or veterinary use. Sold exclusively as a research compound for licensed laboratory settings. Nothing here constitutes medical advice.

Hexarelin is a synthetic, six-amino-acid growth hormone-releasing peptide (GHRP) studied extensively in preclinical research for its ability to stimulate growth hormone release via the GHS-R1a receptor — the same receptor activated by ghrelin. It is one of the most potent synthetic GHRPs documented in animal research, and has been studied across somatotropic axis biology, cardiovascular tissue, and metabolic function. Researchers can source Hexarelin from Palmetto Peptides with ≥98% HPLC purity and full lot-specific CoA documentation.

Last Updated: April 21, 2026 | Reading Time: Approximately 3 minutes | Author: Palmetto Peptides Research Team

Quick Answer

Hexarelin is a synthetic, six-amino-acid growth hormone-releasing peptide (GHRP) studied extensively in preclinical research for its ability to stimulate growth hormone release via the GHS-R1a receptor — the same receptor activated by ghrelin.

Background and Development

Hexarelin emerged from structure-activity relationship work aimed at optimizing the GHRP-6 scaffold. The key modification — substituting D-tryptophan at position 2 with D-2-methyltryptophan — increased GHS-R1a binding affinity, improved metabolic stability, and produced more potent GH-releasing responses in preclinical models. By the mid-1990s, hexarelin had been characterized in rodent models, non-human primates, and limited early-phase pharmacokinetic studies.

Molecular Structure

Sequence: His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂ | MW: ~887.0 g/mol | CAS: 140703-51-1 | Receptor: GHS-R1a (full agonist). Contains two D-amino acids critical for receptor geometry and enzymatic resistance. The C-terminal amide contributes to receptor binding and plasma stability.

Mechanism of Action: GHS-R1a Signaling

Hexarelin binds GHS-R1a, a Gq/11-coupled GPCR expressed in pituitary somatotrophs, hypothalamus, cardiac tissue, and peripheral organs. Binding triggers: (1) Gq/11 activation → (2) PLCβ stimulation → (3) IP3-mediated calcium release from endoplasmic reticulum → (4) GH vesicle exocytosis. GH peaks 15–30 min post-administration in rodent models and returns to baseline by 90–120 min. Hexarelin also modulates hypothalamic somatostatin tone and exerts GH-independent effects in cardiac tissue via peripheral GHS-R1a receptors.

Preclinical Research Findings

GH secretion: Robust, dose-dependent GH pulses — among the largest for any synthetic GHRP in rodent models

IGF-1 axis: Sustained protocols document measurable IGF-1 elevation, especially in GH-deficient animal models

Cardiac tissue: GH-independent GHS-R1a activity in cardiomyocytes documented; findings in ischemic cardiac models in animals

Adrenocortical: Modest ACTH/cortisol elevation alongside GH response — distinguishes hexarelin from ipamorelin

Metabolic: Body composition observations in GH-deficient rodent models, primarily downstream of GH activation

Hexarelin vs. Related GHRPs

Hexarelin

Very High

Broad

Pronounced

Extensive

Ipamorelin

Moderate

High (GH-selective)

Low

Limited

GHRP-6

Moderate-High

CJC-1295

High (GHRH axis)

High

Minimal

Protocol Considerations

Doses in literature: 50–300 mcg/kg rodent; most GH response studies use 100–200 mcg/kg SC. Receptor desensitization is the critical protocol variable — twice-daily dosing for 1–4 weeks produces significant GH attenuation. Researchers use intermittent schedules (every other day or 3×/week), washout periods, and baseline/endpoint GH measurements. GH peak sampling window: 15–30 min post-dose.

Storage and Reconstitution

Lyophilized: stable 12–24 months at -20°C in sealed desiccated vials away from light. Reconstitute with bacteriostatic water — add solvent gently along vial wall, swirl (do not vortex). Reconstituted: stable up to 30 days at 2–8°C with BAC water. Aliquot and store at -80°C for extended use. Avoid freeze-thaw cycling.

Quality Standards for Research Sourcing

Minimum ≥95% HPLC purity for in vitro work; ≥98% preferred for in vivo animal studies. CoA must include MS identity confirmation (~887.0 g/mol), HPLC chromatogram, and endotoxin testing data for in vivo applications. Palmetto Peptides Hexarelin is third-party verified with full lot-specific documentation. Use the Reconstitution Calculator for working concentration prep.

Cluster Articles

What Is Hexarelin? Mechanism of Action Explained

Hexarelin vs. Ipamorelin: Research Comparison

Hexarelin Dosage Protocols in Research Settings

Hexarelin Half-Life and Stability

How Hexarelin Interacts with GHS-R1a

Hexarelin Research Benefits: Published Study Review

Hexarelin Side Effects: Research Safety Profile

Hexarelin Storage Guidelines for Research Labs

Hexarelin and IGF-1 Response

Where to Buy Hexarelin for Research

Hexarelin vs. GHRP-6

Hexarelin Synthesis and Manufacturing

Related research: hexarelin mechanism of action, hexarelin preclinical research findings, and hexarelin vs ipamorelin research.

Cluster Articles

Best Practices for Storing Hexarelin in Research Environments

Hexarelin and IGF-1 Response: What Preclinical Research Suggests

Hexarelin Dosage in Research Settings: Common Protocol Structures

Hexarelin Half-Life and Stability: What Research Shows

Hexarelin Research Benefits: Review of Published Preclinical Studies

Hexarelin Side Effects in Research Studies: Safety Profile Overview

Hexarelin vs. GHRP-6: Comparing Two Growth Hormone Releasing Peptides

Hexarelin vs. Ipamorelin: Key Differences in Research Applications

How Hexarelin Interacts with the Ghrelin Receptor (GHS-R1a) in Research Models

How Hexarelin Is Synthesized: Peptide Manufacturing Overview for Research Procurement

What Is Hexarelin? Mechanism of Action in Research Models Explained

Where to Buy Hexarelin for Research: Quality and Purity Considerations

Related Research Articles